A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit
Titel:
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit
Auteur:
Anastasopoulou, Eleftheria A. Voutsas, Ioannis F. Keramitsoglou, Theodora Gouttefangeas, Cécile Kalbacher, Hubert Thanos, Anastasios Papamichail, Michael Perez, Sonia A. Baxevanis, Constantin N.